Global Metastatic Melanoma Therapeutics Market Anticipates Robust Growth with New Therapeutic Developments
March 27, 2024 15:46 ET
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Metastatic Melanoma Therapeutics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Market Growth and...
Capecitabine Global Market Report 2024
March 06, 2024 04:09 ET
|
Research and Markets
Dublin, March 06, 2024 (GLOBE NEWSWIRE) -- The "Capecitabine Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The capecitabine market size is expected to see...
Nivolumab Market Forecasts Indicate Robust Growth Driven by Advances in Cancer Immunotherapy and Increased Global Access to Care
February 15, 2024 14:57 ET
|
Research and Markets
Dublin, Feb. 15, 2024 (GLOBE NEWSWIRE) -- The "Nivolumab Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Recent advancements in cancer treatment and the...
Global Melanoma Therapeutics Market Set for Remarkable Growth, Projected to Reach $6.16 Billion by 2028
February 08, 2024 11:37 ET
|
Research and Markets
Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The "Melanoma Therapeutics Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The global melanoma therapeutics market is...
Global Basal Cell Carcinoma Treatment Market Poised for Significant Growth, Forecasted Expansion at a CAGR of 8.12% from 2024-2034
February 01, 2024 09:29 ET
|
Research and Markets
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Global Basal Cell Carcinoma Treatment Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The...
MTG201 + Nivolumab Drug and Market Analysis 2023-2032: Sales Analytics, Clinical Assessment, SWOT Analysis, Emerging Competitors
January 30, 2024 10:50 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "MTG201 + nivolumab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report provides...
Analysis of INOVIO's INO-5401 & INO-9012 and Regeneron & Sanofi's LIBTAYO (Cemiplimab) Treatment for Glioblastoma Multiforme (GBM): Drug Insights, Regulatory Landscape, and Market Forecast to 2032
January 30, 2024 07:29 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "INO-5401 + INO-9012 + LIBTAYO Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This...
Global Actinic Keratosis Treatment Market Analysis, Share, Growth, Trends and Forecast to 2031, Featuring Sun Pharmaceutical, Biofrontera, Nestle, Novartis, GlaxoSmithKline, Almirall & LEO Pharma
January 26, 2024 04:12 ET
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Actinic Keratosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
Melanoma Drugs - $13.98 Billion Industry Opportunity Assessment, 2024-2028: Regional Insights and Competitor Market Shares
January 24, 2024 13:39 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Melanoma Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global melanoma drugs market has grown...
Capecitabine Market Research Reveals Significant Growth in Oncology Treatment Sector
January 09, 2024 18:48 ET
|
Research and Markets
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "Capecitabine Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The latest market research on capecitabine, a...